Epigenetics and Monoclonal histone modification antibodies
How epigenetic alterations on histones are strong biomarkers of disease evolution and how to target these post-translational modifications effectively with SYnAbs higher specific mouse and rat monoclonal antibodies
SYnAbs enters in a strategic agreement with Volition to generate monoclonal antibodies against epigenetics biomarkers including modifications of histones and DNA, histone variants, and proteins associated with nucleosomes
SYnAbs generates highly specific custom monoclonal antibodies for epigenetic identification : trimethylation, dimethylation, mutation, acetylation, citrullination and other modifications on DNA